Cargando…
Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
INTRODUCTION: Allergic rhinitis (AR) is a widespread disease with increasing prevalence in developed countries. The only treatment that tackles the underlying causes is allergen immunotherapy (AIT). This treatment is performed through two application routes, the subcutaneous immunotherapy (SCIT) or...
Autores principales: | Pfaar, Oliver, Richter, Hartmut, Sager, Angelika, Miller, Christoph, Müller, Thomas, Jutel, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163374/ https://www.ncbi.nlm.nih.gov/pubmed/37227419 http://dx.doi.org/10.1002/clt2.12245 |
Ejemplares similares
-
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitis
por: Novak, Natalija, et al.
Publicado: (2022) -
Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients
por: Pfaar, Oliver, et al.
Publicado: (2015) -
Allergen-Specific Immunotherapy in Asthma
por: Jutel, Marek
Publicado: (2014) -
A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023) -
Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
por: Vogelberg, Christian, et al.
Publicado: (2022)